Rohto Pharmaceutical Co.,Ltd. (TYO:4527)

Market Cap	514.18B
Revenue (ttm)	295.57B
Net Income (ttm)	29.59B
Shares Out	225.96M
EPS (ttm)	129.30
PE Ratio	17.60
Forward PE	15.45
Dividend	40.00 (1.76%)
Ex-Dividend Date	Mar 28, 2025

Volume	1,374,900
Average Volume	1,518,630
Open	2,305.00
Previous Close	2,290.50
Day's Range	2,260.50 - 2,308.00
52-Week Range	2,138.00 - 3,688.00
Beta	-0.26
RSI	49.45
Earnings Date	May 13, 2025

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatologi...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1899
• Employees: 7,259
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4527

Financial Performance

In 2023, Rohto Pharmaceutical's revenue was 270.84 billion, an increase of 13.48% compared to the previous year's 238.66 billion. Earnings were 30.94 billion, an increase of 17.28%.